Pancreatic cancer test to offer life-saving early diagnosis

Thursday, 21 November, 2019
An innovative Swedish SME will soon launch a life-saving test for one of the most lethal and hard-to-detect forms of cancer. Clinically validated in an EU-funded project, the test could revolutionise the diagnosis of pancreatic cancer, providing early detection with unprecedented accuracy, boosting patient survival rates and enabling widespread screening of high-risk groups.
Article
#H2020

#H2020